AtriCure, Inc. is a medical device company that provides innovative solutions designed to to deliver best-in-class solutions. AtriCure’s Synergy™ Ablation System approved for the treatment of persistent & longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures. Hybrid AF™ Therapy with the EPi-Sense Device is a subxiphoid epicardial ablation therapy for patients with long-standing persistent Afib. The AtriClip LAA Exclusion used during concomitant cardiac surgery worldwide. Cryo Nerve Block Therapy for post-op pain management.